Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 1
1956 2
1960 1
1962 1
1963 1
1964 1
1965 1
1966 1
1967 1
1970 1
1972 1
1982 1
1985 1
1987 1
1988 2
1992 1
1995 2
1996 1
1998 1
1999 3
2000 1
2001 1
2002 2
2003 2
2004 3
2005 3
2006 5
2007 2
2008 3
2009 5
2010 8
2011 3
2012 3
2013 1
2014 2
2015 9
2016 10
2017 4
2018 3
2019 8
2020 9
2021 10
2022 7
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Results by year

Filters applied: . Clear all
Page 1
Whole-genome characterization of chemoresistant ovarian cancer.
Patch AM, Christie EL, Etemadmoghadam D, Garsed DW, George J, Fereday S, Nones K, Cowin P, Alsop K, Bailey PJ, Kassahn KS, Newell F, Quinn MC, Kazakoff S, Quek K, Wilhelm-Benartzi C, Curry E, Leong HS; Australian Ovarian Cancer Study Group; Hamilton A, Mileshkin L, Au-Yeung G, Kennedy C, Hung J, Chiew YE, Harnett P, Friedlander M, Quinn M, Pyman J, Cordner S, O'Brien P, Leditschke J, Young G, Strachan K, Waring P, Azar W, Mitchell C, Traficante N, Hendley J, Thorne H, Shackleton M, Miller DK, Arnau GM, Tothill RW, Holloway TP, Semple T, Harliwong I, Nourse C, Nourbakhsh E, Manning S, Idrisoglu S, Bruxner TJ, Christ AN, Poudel B, Holmes O, Anderson M, Leonard C, Lonie A, Hall N, Wood S, Taylor DF, Xu Q, Fink JL, Waddell N, Drapkin R, Stronach E, Gabra H, Brown R, Jewell A, Nagaraj SH, Markham E, Wilson PJ, Ellul J, McNally O, Doyle MA, Vedururu R, Stewart C, Lengyel E, Pearson JV, Waddell N, deFazio A, Grimmond SM, Bowtell DD. Patch AM, et al. Among authors: shackleton m. Nature. 2015 May 28;521(7553):489-94. doi: 10.1038/nature14410. Nature. 2015. PMID: 26017449
Whole-genome landscapes of major melanoma subtypes.
Hayward NK, Wilmott JS, Waddell N, Johansson PA, Field MA, Nones K, Patch AM, Kakavand H, Alexandrov LB, Burke H, Jakrot V, Kazakoff S, Holmes O, Leonard C, Sabarinathan R, Mularoni L, Wood S, Xu Q, Waddell N, Tembe V, Pupo GM, De Paoli-Iseppi R, Vilain RE, Shang P, Lau LMS, Dagg RA, Schramm SJ, Pritchard A, Dutton-Regester K, Newell F, Fitzgerald A, Shang CA, Grimmond SM, Pickett HA, Yang JY, Stretch JR, Behren A, Kefford RF, Hersey P, Long GV, Cebon J, Shackleton M, Spillane AJ, Saw RPM, López-Bigas N, Pearson JV, Thompson JF, Scolyer RA, Mann GJ. Hayward NK, et al. Among authors: shackleton m. Nature. 2017 May 11;545(7653):175-180. doi: 10.1038/nature22071. Epub 2017 May 3. Nature. 2017. PMID: 28467829
UHRF1/UBE2L6/UBR4-mediated ubiquitination regulates EZH2 abundance and thereby melanocytic differentiation phenotypes in melanoma.
Kuser-Abali G, Zhang Y, Szeto P, Zhao P, Masoumi-Moghaddam S, Fedele CG, Leece I, Huang C, Cheung JG, Ameratunga M, Noguchi F, Andrews MC, Wong NC, Schittenhelm RB, Shackleton M. Kuser-Abali G, et al. Among authors: shackleton m. Oncogene. 2023 Apr;42(17):1360-1373. doi: 10.1038/s41388-023-02631-8. Epub 2023 Mar 11. Oncogene. 2023. PMID: 36906655 Free PMC article.
Symptomatic brain metastases in melanoma.
Knox A, Wang T, Shackleton M, Ameratunga M. Knox A, et al. Among authors: shackleton m. Exp Dermatol. 2024 Apr;33(4):e15075. doi: 10.1111/exd.15075. Exp Dermatol. 2024. PMID: 38610093 Review.
Personalised surveillance after treatment for high-risk cancer.
Guo C, Lewin J, Shackleton M. Guo C, et al. Among authors: shackleton m. Oncotarget. 2019 Jan 22;10(7):694-695. doi: 10.18632/oncotarget.26619. eCollection 2019 Jan 22. Oncotarget. 2019. PMID: 30774771 Free PMC article. No abstract available.
An update on adjuvant systemic therapies in melanoma.
Samuel E, Moore M, Voskoboynik M, Shackleton M, Haydon A. Samuel E, et al. Among authors: shackleton m. Melanoma Manag. 2019 Nov 13;6(3):MMT28. doi: 10.2217/mmt-2019-0009. Melanoma Manag. 2019. PMID: 31807279 Free PMC article. Review.
Progress in understanding melanoma propagation.
Shackleton M, Quintana E. Shackleton M, et al. Mol Oncol. 2010 Oct;4(5):451-7. doi: 10.1016/j.molonc.2010.06.006. Epub 2010 Jun 23. Mol Oncol. 2010. PMID: 20655286 Free PMC article. Review.
Reduced melanoma referrals during COVID-19 lockdown.
Berry W, Tan K, Haydon A, Shackleton M, Mar VJ. Berry W, et al. Among authors: shackleton m. Aust J Gen Pract. 2021 Jan 22;50. doi: 10.31128/AJGP-COVID-45. Aust J Gen Pract. 2021. PMID: 33543153 Free article.
Current management of advanced melanoma: a transformed landscape.
Gyorki DE, Spillane J, Speakman D, Shackleton M, Henderson MA. Gyorki DE, et al. Among authors: shackleton m. ANZ J Surg. 2014 Sep;84(9):612-7. doi: 10.1111/ans.12673. Epub 2014 May 20. ANZ J Surg. 2014. PMID: 24842394 Review.
128 results